TY  - GEN
AU  - Lorenz,Katrin
AU  - Scheller,Yvonne
AU  - Bell,Katharina
AU  - Grus,Franz
AU  - Ponto,Katharina A
AU  - Bock,Felix
AU  - Cursiefen,Claus
AU  - Flach,Jens
AU  - Gehring,Marta
AU  - Peto,Tunde
AU  - Silva,Rufino
AU  - Tal,Yossi
AU  - Pfeiffer,Norbert
TI  - A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial
SN  - 1745-6215
PY  - 2018///0305
KW  - Administration, Ophthalmic
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Clinical Protocols
KW  - Double-Blind Method
KW  - Europe
KW  - Glaucoma, Neovascular
KW  - etiology
KW  - Gonioscopy
KW  - Humans
KW  - Insulin Receptor Substrate Proteins
KW  - genetics
KW  - Intraocular Pressure
KW  - drug effects
KW  - Neovascularization, Pathologic
KW  - Oligonucleotides
KW  - Ophthalmic Solutions
KW  - Prospective Studies
KW  - Research Design
KW  - Retinal Neovascularization
KW  - Retinal Vein Occlusion
KW  - complications
KW  - Signal Transduction
KW  - Time Factors
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - metabolism
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s13063-017-1861-3
ER  -